June 10, 2023
RegMed Investors’ (RMi) closing bell: the tug-a- war of algorithms siding with electronic trade versus downslides
June 8, 2023
RegMed Investors’ (RMi) closing bell: slipping and sliding as goes the sector
June 7, 2023
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector initiating a fifth (5th) uplifted session
June 6, 2023
RegMed Investors’ (RMi) closing bell: cell and gene therapy swells as Nasdaq uplifts
June 3, 2023
RegMed Investors’ (RMi) closing bell: investors escaped the debt ceiling conflagration helping sentiment
May 31, 2023
RegMed Investors’ (RMi) closing bell: deal or no deal
May 25, 2023
RegMed Investors’ (RMi) closing bell: another breakdown in sector’s share pricing
May 24, 2023
RegMed Investors’ (RMi) closing bell: sector share pricing rolls downhill
May 23, 2023
RegMed Investors’ (RMi) closing bell: sector is affected by debt ceiling “talks” insinuating a Biden default
May 22, 2023
RegMed Investors’ (RMi) closing bell: Sector runs to the upside versus sitting on the sidelines
May 18, 2023
RegMed Investors’ (RMi) closing bell: too many factors are calling the ball on share pricing
May 16, 2023
RegMed Investors’ (RMi) closing bell: biotech, cell and gene therapy sector sinks
May 15, 2023
RegMed Investors’ (RMi) closing bell: a waiting game
May 12, 2023
RegMed Investors’ (RMi) closing bell: sector sentiment and conviction dampened by economic/inflation headwinds
May 11, 2023
RegMed Investors’ (RMi) closing bell: under pressure with share pricing deceleration
May 10, 2023
RegMed Investors’ (RMi) closing bell: economic expectation influences share pricing reality
4 hours 20 min ago
RegMed Investors’ (RMi) pre-open: Waiting the wait
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors